Suprasorb® P + PHMB

    Antimicrobial PU Foam Dressing

    Suprasorb P + PHMB with perforated wound contact layer impresses with its reliable absorption of exudate. The PHMB incorporated in the foam is effective both in the dressing and in the wound. This is why Suprasorb P + PHMB is classified as a Class III medical device.

    The material is soft and conformable. The special surface structure of the Suprasorb P + PHMB wound contact layer is gentle on easily injured surfaces like healing wounds. The semipermeable PU carrier layer maintains a moist wound healing environment. Impermeable to bacteria and water.

    Suprasorb P + PHMB is suitable for use under compression bandages.

    Ordering information

    Suprasorb P + PHMB

    non-adhesive
    Dimensions (cm)REFSC/TC
    5 x 53454010/100
    7.5 x 7.53454110/100
    10 x 103454210/100
    10 x 20345435/50
    15 x 15345445/50
    20 x 20345455/50

    Fields of application

    • moderately to heavily exuding wounds
    • for wounds that are infected and at risk of infection
    • for superficial wounds

    Wound healing stages:

    • Exudation phase
    • Granulation phase
    • Epithelialisation phase

    Indications

    • leg and foot ulcers
    • decubital ulcers
    • diabetic ulcers
    • postoperative surgical wounds

    Properties

    • reliable exudate management
    • broad antimicrobial action
    • rapid and prolonged effect
    • with a perforated wound contact layer
    • water- and bacteria-proof

    To note

    • Suprasorb P + PHMB can be used as a secondary dressing with wounds at risk of infection and infected wounds within the scope of a regular antimicrobial therapy regimen.
    • When dry, Suprasorb P + PHMB can easily be cut to the size of the individual wound.

    Downloads

    Find our brochures as PDF files in our download section. Go to downloads

     
    51

    Report AMS P2337R, data on file

     
    52

    Report AMS OT50 rev.5, data on file

     
    53

    Report AMS P2999R, data on file, relates to Ps. aeruginosa and Staph. aureus, effective for 7 days

     
    54

    Report AMS LD017, P2412, data on file

    This website contains information on products and medical practices which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. Medical practices and regulations can be different from one country to another.